![]() |
市场调查报告书
商品编码
1666158
全球微波消融设备市场 - 2025 年至 2033 年Global Microwave Ablation Devices Market - 2025-2033 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
2024 年全球微波消融设备市场规模达到 3.7816 亿美元,预计到 2033 年将达到 11.4574 亿美元,2025-2033 年预测期内的复合年增长率为 13.0%。
微波消融设备是利用微波能量破坏异常组织(如肿瘤或有害生长物)的医疗仪器。它们发射高频电磁波,引起组织中的水分子振动并产生热量,导致凝固性坏死。它们广泛用于肿瘤学治疗肝臟、肺臟、肾臟、骨肿瘤、心血管、泌尿和妇科疾病。与其他热消融技术相比,微波消融具有更深的组织穿透力、更高的温度和更快的治疗时间。
驱动因素与约束因素
癌症和其他慢性疾病发生率不断上升
微波消融设备市场的发展受到癌症和其他需要微创治疗的慢性疾病发生率上升的推动。由于全球肝臟、肺臟和肾臟肿瘤的负担,与传统手术方法相比,微波消融具有手术时间更快、组织破坏效率更高、併发症更少等特征。医院和门诊手术中心采用影像导引消融技术也推动了市场成长。
例如,根据美国癌症协会根据中央癌症登记处和国家卫生统计中心的资料预测,到 2024 年,美国将出现 2,001,140 例新癌症病例和 611,720 例死亡病例。
严格的监管审批
由于 FDA 和 EMA 严格的监管审批和合规要求,微波消融设备市场面临重大挑战。这些指南确保设备在进入市场之前的安全性和有效性。审批过程非常耗时,需要大量的临床试验、文件和品质控制措施。这可能会延迟产品发布、增加成本和复杂性,这可能会限制市场成长。
The Global Microwave Ablation Devices Market reached US$ 378.16 million in 2024 and is expected to reach US$ 1145.74 million by 2033, growing at a CAGR of 13.0% during the forecast period 2025-2033.
Microwave ablation devices are medical instruments that use microwave energy to destroy abnormal tissues, such as tumors or unwanted growths. They emit high-frequency electromagnetic waves, causing water molecules in tissues to vibrate and produce heat, leading to coagulative necrosis. They are widely used in oncology for treating liver, lung, kidney, bone tumors, cardiovascular, urological, and gynecological procedures. Compared to other thermal ablation techniques, microwave ablation offers deeper tissue penetration, higher temperatures, and faster treatment times.
Market Dynamics: Drivers & Restraints
Increasing Prevalence of Cancer and Other Chronic Diseases
The microwave ablation devices market is driven by the rising prevalence of cancer and other chronic diseases requiring minimally invasive treatments. With the global burden of liver, lung, and kidney tumors, microwave ablation offers faster procedure times, higher tissue destruction efficiency, and reduced complications compared to traditional surgical methods. The adoption of image-guided ablation techniques in hospitals and ambulatory surgical centers is also driving market growth.
For instance, according to American Cancer Society predicts in 2024, the US experienced 2,001,140 new cancer cases and 611,720 deaths, based on data from central cancer registries and the National Center for Health Statistics.
Stringent Regulatory Approvals
The microwave ablation devices market faces significant challenges due to stringent regulatory approvals and compliance requirements from the FDA and EMA. These guidelines ensure safety and efficacy of devices before they reach the market. The approval process is time-consuming and requires extensive clinical trials, documentation, and quality control measures. This can delay product launches, increase costs, and complexity, potentially limiting market growth.
The global Microwave Ablation Devices market is segmented based on Component Type, Application, End User and Region.
Generator segment is expected to dominate the Microwave Ablation Devices market share
The generator segment holds a major portion of the microwave ablation devices market share and is expected to continue to hold a significant portion of the microwave ablation devices market share during the forecast period.
Microwave ablation devices rely on generators for energy generation, controlling the frequency, power output, and duration of microwave emissions. Advancements in generator technology, including improved energy efficiency, real-time monitoring, and integration with imaging systems, enhance the accuracy and safety of ablation procedures. The growing demand for generators with higher power output and better thermal control drives market innovations, contributing to the expansion of microwave ablation therapies.
End User:-
Hospitals segment is the fastest-growing segment in Microwave Ablation Devices market share
The hospitals segment is the fastest-growing segment in the Microwave Ablation Devices market share and is expected to hold the market share over the forecast period.
Hospitals are leading the market in microwave ablation devices due to their primary role in healthcare. With increasing cases of cancer and chronic diseases requiring ablation therapy, hospitals invest in advanced systems for minimally invasive treatment. Specialized oncology and radiology departments enable the integration of microwave ablation with imaging technologies like CT and ultrasound. Government funding, reimbursement policies, and skilled healthcare professionals support the widespread use of microwave ablation devices in clinical practice.
For instance, in January 2025, Sringeri Sharada Equitas (SSE) hospital in Chennai has introduced Microwave Ablation treatment for affordable cancer treatment and curing, using microwave energy to kill and shrink tumor cells in organs like kidney, lungs, and liver.
North America is expected to hold a significant position in the Microwave Ablation Devices market share
North America holds a substantial position in the Microwave Ablation Devices market and is expected to hold most of the market share due to advanced healthcare infrastructure, minimally invasive procedures, and investment in medical technology innovation. Key players like Medtronic and Boston Scientific develop cutting-edge ablation technologies. The rising prevalence of cancer, particularly liver and lung cancer, and government initiatives for treatment also increase demand for microwave ablation procedures. Favorable reimbursement policies and skilled healthcare professionals further contribute to market expansion.
For instance, in July 2024, Siemens Healthineers' Varian has received FDA clearance for its IntelliBlate microwave ablation system, designed for soft tissue ablation. The system offers clinicians greater predictability, precision, and control, forming the foundation of a future-focused, integrated microwave ablation ecosystem.
Europe is growing at the fastest pace in the Microwave Ablation Devices market
Europe holds the fastest pace in the Microwave Ablation Devices market and is expected to hold most of the market share is driven by rising healthcare expenditure, increased awareness of minimally invasive cancer treatments, and advancements in imaging technology. Countries like Germany, France, and the UK are leading due to strong research and development, rising cancer cases, well-regulated healthcare policies, and funding for cancer treatment programs. The expansion of ambulatory surgical centers and preference for outpatient procedures also contribute to market growth.
For instance, in March 2024, Creo Medical Group has made significant progress in the field of minimally invasive surgical endoscopy for pre-cancer and cancer patients. Professor Pallav Shah and Dr Christopher Orton at the Royal Brompton Hospital have become the first specialists to perform a robotic guided microwave ablation of lung tissue in the same sitting as a diagnostic procedure. The procedure, which took three minutes, involved the ablation of a 27mm cancerous nodule in a patient's lung.
The major global players in the Microwave Ablation Devices market include AngioDynamics, Medtronic Plc, Boston Scientific Corporation, Johnson & Johnson Inc, Emblation, MedWaves, Inc, Symple Surgical, Urologix, LLC, Varian Medical Systems Inc, Huber Suhner and among others.
The global Microwave Ablation Devices market report delivers a detailed analysis with 61 key tables, more than 59 visually impactful figures, and 210 pages of expert insights, providing a complete view of the market landscape.
Target Audience 2024
Key Market Players
Emerging Market Players
LIST NOT EXHAUSTIVE